Vidarabine (monohydrate), 50mg

3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole, 95.0%, 5g

4,4,5,5-Tetramethyl-2-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane, 95.0%, 250mg

BENZENEPENTACARBOXYLIC ACID, 98%, 1g

5-Fluoro-2-methoxypyridin-4-amine, 95.0%, 1g

5-Bromo-2,4-difluorophenylboronic acid, 97%, 25g

4-Nitro-3-(trifluoromethyl)benzaldehyde, 95.0%, 5g

(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-methyl-amine, 98.0%, 5g

N-(4-Cyanophenyl)piperidine-4-carboxylic acid, 97.0%, 1g

4,4,4-Trifluorocrotonic acid, 97.0%, 1g

tert-butyl 3-oxo-2H,3H,3aH,4H,5H,6H,7H-pyrazolo[4,3-b]pyridine-4-carboxylate, 97%, 1g

Methyl 5-((tert-butoxycarbonyl)amino)thiazole-2-carboxylate, 98%, 1g

3-Bromophenetole>98.0%(GC)25g